Todd Waldman

13.9k citations
68 papers · 10.9k · 5 hit papers · h-index 40

Impact in

Papers in

    • PI3K/AKT/mTOR signaling in cancer 15
    • Genomics and Chromatin Dynamics 13
    • Epigenetics and DNA Methylation 9
    • Ubiquitin and proteasome pathways 7
    • CRISPR and Genetic Engineering 7
    • Cancer-related Molecular Pathways 20

Todd Waldman

67 papers receiving 10.8k citations

Todd Waldman's Hit Papers

Disruption of p53 in human cancer cells alters the responses to therapeutic agents 1999 · 886 citations
8860+10+20Years since publication50010001.5k2.0k

Peers

Todd Waldman
Comparison fields: 5 of 123
  • Oncology 5.2k
  • Cancer Research 1.7k
  • Molecular Biology 7.5k
  • Biotechnology 857
  • Genetics 761
Replace Jiřina Bártková with:
Jiřina Bártková Denmark
Joyce M. Slingerland United States
Gerard P. Zambetti United States
Ygal Haupt Australia
Stephen N. Jones United States
Gabriela Dontu United States
Gary E. Gallick United States
Klas G. Wiman Sweden
Jun‐ya Kato Japan
Christophe Ginestier France
Todd Waldman relative to Jiřina Bártková Denmark Jiřina Bártková's profile →
Citations per field
00.5×1.5×
Jiřina Bártková · 1×
Citations per year

Countries citing papers authored by Todd Waldman

Since Specialization
Citations

This map shows the geographic impact of Todd Waldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Waldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Waldman more than expected).

Fields of papers citing papers by Todd Waldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Waldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Waldman. The network helps show where Todd Waldman may publish in the future.

Co-authors

The 25 scholars most cited alongside Todd Waldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Todd Waldman Line = papers co-authored together Todd Waldman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Hit paper breakdown →
19982487
2
p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
Hit paper breakdown →
19951068
3
Disruption of p53 in human cancer cells alters the responses to therapeutic agents
Hit paper breakdown →
1999886
4
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Hit paper breakdown →
1996638
5
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
Hit paper breakdown →
1995526
6 2009492
7 1996435
8 2014349
9 1997330
10 2011314
11 2010257
12 2010231
13 2006187
14 2009165
15 1994153
16 2012149
17
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.
2002143
18
Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.
1996141
19 2006128
20 2011113

About Todd Waldman

Todd Waldman is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Cell Biology, having authored 68 papers that have together received 10.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), PI3K/AKT/mTOR signaling in cancer (15 papers), Genomics and Chromatin Dynamics (13 papers), Glioma Diagnosis and Treatment (10 papers), Epigenetics and DNA Methylation (9 papers), Cancer Genomics and Diagnostics (8 papers), Ubiquitin and proteasome pathways (7 papers) and CRISPR and Genetic Engineering (7 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (1.7k citations), Molecular Biology (7.5k citations), Biotechnology (857 citations) and Genetics (761 citations). Todd Waldman has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Bert Vogelstein, Kenneth W. Kinzler, Christoph Lengauer, Fred Bunz, K. W. Kinzler, Jung-Sik Kim, Steven Zhou, Jeremy Brown, Annie Dutriaux and John M. Sedivy. Their work appears in journals such as Cancer Research, Neuro-Oncology, Journal of Biological Chemistry, Molecular and Cellular Biology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact